References
- Giansanti V, Torriglia A, Scovassi AI. Conversation between apoptosis and autophagy: “Is it your turn or mine?”. Apoptosis 2011; 16:321 - 33; http://dx.doi.org/10.1007/s10495-011-0589-x; PMID: 21404107
- Gewirtz DA. Cytoprotective and nonprotective autophagy in cancer therapy. Autophagy 2013; 9:1263 - 5; http://dx.doi.org/10.4161/auto.25233; PMID: 23800720
- Klionsky DJ, Abdalla FC, Abeliovich H, Abraham RT, Acevedo-Arozena A, Adeli K, Agholme L, Agnello M, Agostinis P, Aguirre-Ghiso JA, et al. Guidelines for the use and interpretation of assays for monitoring autophagy. Autophagy 2012; 8:445 - 544; http://dx.doi.org/10.4161/auto.19496; PMID: 22966490
- Soto-Pantoja DR, Miller TW, Pendrak ML, DeGraff WG, Sullivan C, Ridnour LA, Abu-Asab M, Wink DA, Tsokos M, Roberts DD. CD47 deficiency confers cell and tissue radioprotection by activation of autophagy. Autophagy 2012; 8:1628 - 42; http://dx.doi.org/10.4161/auto.21562; PMID: 22874555
- Gewirtz DA. The four faces of autophagy: Implications for cancer therapy. Cancer Res 2014; In press
- Ko A, Kanehisa A, Martins I, Senovilla L, Chargari C, Dugue D, Mariño G, Kepp O, Michaud M, Perfettini JL, et al. Autophagy inhibition radiosensitizes in vitro, yet reduces radioresponses in vivo due to deficient immunogenic signalling. Cell Death Differ 2014; 21:92 - 9; http://dx.doi.org/10.1038/cdd.2013.124; PMID: 24037090